MAUNA KEA TECHNOLOGIES - Announcing a New International Society Dedicated to Advancing the Practice of Endomicroscopy

PARIS and CAMBRIDGE, Massachusetts, October 4, 2016 /PRNewswire/ --

Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio^®, the multidisciplinary confocal laser endomicroscopy platform, is pleased by the announcement of the creation of the International Society for Endomicroscopy (IS4E).

The Society was developed from the growing need of healthcare professionals and researchers worldwide to connect and share knowledge in this ever-expanding domain. The society will serve to advance education, research and collaboration among a multi-disciplinary group of professionals. The first activities of the Society will soon to be announced.

Dr David Carr-Locke, Chief, Division of Digestive Diseases, Mount Sinai Beth Israel Medical Center, New York, first President of the IS4E declared "Endomicroscopy is either already or soon-to-be common practice in multiple specialties within gastroenterology, pulmonology, urology, surgery and research in the field of real-time digital in-vivo and ex-vivo microscopy. The creation of this professional community became a necessary step for cross-communication and we can already see membership growing to include experts, daily-users and future practitioners."

Sacha Loiseau, Ph.D., Founder and Chief Executive Officer of Mauna Kea Technologies, said, "There is growing momentum in the adoption of endomicroscopy driven by new clinical data, medical society support, and advances in technology. The creation of an international society is a clear tribute to the importance taken by endomicroscopy in medicine and surgery and its relevance for a growing number of applications. The IS4E will play an important role in bringing together a diverse group of experts to advance the field of endomicroscopy, particularly as it continues to expand into new applications. We congratulate the founding members of the IS4E and look forward to close collaboration in the near future."

The IS4E is an independent organization that welcomes industry support. Mauna Kea Technologies is providing the IS4E with a grant to support the formation and initial activity of the society.

About Mauna Kea Technologies 

Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer thanks to real time in vivo microscopic visualization. The Company's flagship product, Cellvizio, has received clearance to sell a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico. For more information on Mauna Kea Technologies, visit http://www.maunakeatech.com.

Mauna Kea Technologies
Benoit Jacheet
CFO
investors@maunakeatech.com

United States
Zack Kubow / Lee Roth
The Ruth Group
646-536-7020 / 7012
zkubow@theruthgroup.com
 lroth@theruthgroup.com

U.S. Media
Christopher Hippolyte
The Ruth Group
646-536-7023
chippolyte@theruthgroup.com

France and Europe 
NewCap - Investor Relations
Florent Alba
+33 (0)1 44 71 94 94
maunakea@newcap.fr

This is a disclosure announcement from PR Newswire.